<DOC>
	<DOCNO>NCT02206126</DOCNO>
	<brief_summary>The purpose study evaluate effect moderate energy restriction body adiposity , severity OSA , blood pressure , sympathetic activity , oxidative stress , inflammatory biomarkers , metabolic profile endothelial function obese patient OSA .</brief_summary>
	<brief_title>Weight Loss Obstructive Sleep Apnea</brief_title>
	<detailed_description>Introduction : Nutritional intervention weight loss one treatment option obstructive sleep apnea ( OSA ) patient excess body adiposity . However , effect moderate energy restriction , recommend current guideline treatment obesity , OSA yet know . Objective : To evaluate effect moderate energy restriction body adiposity ; severity OSA ; blood pressure ; sympathetic activity ; oxidative stress ; inflammatory biomarkers ; metabolic profile endothelial function obese patient OSA . Methods : A 16-week randomized clinical trial , involve 21 subject obesity ( grade I II ) , age 20-55 year present apnea/hipopnea index ( AHI ) &gt; 5 events/h . Participants randomize 2 group : 11 energy restriction group ( ERG ) 10 control group ( CG ) . The ERG instruct follow energy-restricted diet ( -800 kcal/day ) CG advise change food intake . At begin end study , participant underwent evaluation : OSA equipment Watch- PAT200® include determination follow parameter OSA severity : AHI , minimum O2 saturation , number O2 desaturations &gt; 4 % ; body adiposity ( weight , % body fat circumference waist , hip neck ) ; blood pressure ( BP ) ; sympathetic nervous system activity ( plasma level catecholamine ) ; inflammatory biomarkers ( c-reactive protein adiponectin ) ; oxidative stress ( malondialdehyde ) ; metabolism glucose ( glucose , insulin HOMA-IR ) lipid ( total cholesterol fraction triglyceride ) ; endothelial function ( index reactive hyperemia evaluate Endo - PAT 2000® cellular adhesion molecule ) . The statistical analysis perform software STATA v. 10 . The level statistical significance p &lt; 0.05 .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>age 2055 year body mass index ( BMI ) ≥ 30 kg/m2 &lt; 40 kg/m2 smoke Use dietary supplement Use medication could interfere body weight , metabolic profile blood pressure Use permanent pacemaker ; use αadrenergic blocking agent Recent change ( within previous 6 month ) body weight ( &gt; 3 kg ) , dietary intake intensity frequency physical exercise Diagnosis diabetes mellitus , hypertension , dyslipidemia ( drug treatment ) kidney disease Clinical history thyroid dysfunction , angina pectoris , peripheral vascular disease , peripheral neuropathy , heart failure , liver failure , chronic pulmonary disease , gastroesophageal reflux disease , myocardial infarction stroke ; finger deformity prevents proper use sensor necessary evaluate OSA endothelial function ; previous bilateral cervicalthoracic sympathectomy Pregnant lactate woman allow study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>Weight loss</keyword>
	<keyword>Obesity</keyword>
	<keyword>Sympathetic activity</keyword>
	<keyword>Metabolic profile</keyword>
	<keyword>Endothelial function</keyword>
</DOC>